Liver Transplant Research Today is a free monthly online journal that collates and summarizes the latest research about Liver Transplant, including details on risks, prognosis, procedure, surgery, organ donation.

Volume 1 (2005), Issue 4 (April)

1. Living donor liver transplantation: the historical and cultural basis of policy decisions and ongoing ethical questions.
   Health Policy, 72(2): 175-85. [Abstract] [Full-text]
2. Atypical radiological presentation of progressive multifocal leukoencephalopathy following liver transplantation.
   J Neurovirol, 11(1): 46-50. [Abstract] [Full-text]
3. Primary cutaneous cryptococcal cellulitis secondary to insect bite in an immunosupressed patient after liver transplantation.
   Clin Exp Dermatol, 30(3): 241-3. [Abstract] [Full-text]
4. Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera.
   Hepatology, 41(4): 847-56. [Abstract] [Full-text]
5. Vasopressor administration during liver transplant surgery and its effect on endotracheal reintubation rate in the postoperative period: a prospective, randomized, double-blind, placebo-controlled trial.
   Clin Ther, 27(2): 192-8. [Abstract] [Full-text]
6. Morphometric analysis of primary graft non-function in liver transplantation.
   Histopathology, 46(4): 451-9. [Abstract] [Full-text]
7. Exogenous melatonin enhances bile flow and ATP levels after cold storage and reperfusion in rat liver: implications for liver transplantation.
   J Pineal Res, 38(4): 223-30. [Abstract] [Full-text]
8. Review article: current management of renal dysfunction in the cirrhotic patient.
   Aliment Pharmacol Ther, 21(8): 949-61. [Abstract] [Full-text]
9. Hemolytic uremic syndrome: a fatal outcome after kidney and liver transplantation performed to correct factor h gene mutation.
   Am J Transplant, 5(5): 1146-50. [Abstract] [Full-text]
10. To do or not to do living donor hepatectomy in Jehovah's Witnesses: single institution experience of the first 13 resections.
    Am J Transplant, 5(5): 1141-5. [Abstract] [Full-text]
11. Renal histopathological lesions after orthotopic liver transplantation (OLT).
    Am J Transplant, 5(5): 1120-9. [Abstract] [Full-text]
12. A comparison of tacrolimus and cyclosporine in liver transplantation: effects on renal function and cardiovascular risk status.
    Am J Transplant, 5(5): 1111-9. [Abstract] [Full-text]
13. CTLA4 engagement is required for induction of murine liver transplant spontaneous tolerance.
    Am J Transplant, 5(5): 978-86. [Abstract] [Full-text]
14. Gastric volvulus as a complication of liver transplant.
    Pediatr Radiol, 35(3): 327-9. [Abstract] [Full-text]
15. Liver transplantation for malignancy.
    Oncologist, 10(4): 269-81. [Abstract] [Full-text]
16. Role of protein synthesis in the protection conferred by ozone-oxidative-preconditioning in hepatic ischaemia/reperfusion.
    Transpl Int, 18(5): 604-12. [Abstract] [Full-text]
17. Assignment of steatotic livers by the Mayo model for end-stage liver disease.
    Transpl Int, 18(5): 577-83. [Abstract] [Full-text]
18. Predictors of death on the waiting list for liver transplantation characterized by a long waiting time.
    Transpl Int, 18(5): 572-6. [Abstract] [Full-text]
19. Angioplasty treatment of hepatic vein stenosis in pediatric liver transplants: long-term results.
    Transpl Int, 18(5): 556-61. [Abstract] [Full-text]
20. Differences of perioperative liver function, transfusion, and complications according to the type of hepatectomy in living donors.
    Transpl Int, 18(5): 548-55. [Abstract] [Full-text]
21. Liver transplantation with preservation of the inferior vena cava in case of symptomatic adult polycystic disease.
    Transpl Int, 18(5): 513-8. [Abstract] [Full-text]
22. Reliability of hepatic artery configuration in 3D CT angiography compared with conventional angiography--special reference to living-related liver transplant donors.
    Transpl Int, 18(5): 499-505. [Abstract] [Full-text]
23. Liver transplantation in alcoholic patients.
    Transpl Int, 18(5): 491-8. [Abstract] [Full-text]
24. Acute disseminated encephalomyelitis after liver transplantation.
    Arch Neurol, 62(4): 650-2. [Abstract] [Full-text]
25. Post-transplant IVC occlusion and thrombosis treated with tPA, heparin, and sharp recanalization.
    J Gastroenterol, 40(3): 302-5. [Abstract] [Full-text]
26. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation.
    Gut, 54(5): 691-7. [Abstract] [Full-text]
27. Liver transplantation for hepatocellular carcinoma: is expansion of criteria justified?
    Clin Liver Dis, 9(2): 315-28. [Abstract] [Full-text]
28. Twenty-year experience with liver transplantation for hepatocellular carcinoma.
    Arch Surg, 140(4): 353-8. [Abstract] [Full-text]
29. Pegylated versus standard interferon-alpha in antiviral regimens for post-transplant recurrent hepatitis C: Comparison of tolerability and efficacy.
    J Gastroenterol Hepatol, 20(4): 577-82. [Abstract] [Full-text]
30. Recurrence of migraine with aura due to tacrolimus therapy in a liver transplant recipient successfully treated with sirolimus substitution.
    Headache, 45(3): 245-6. [Abstract] [Full-text]
31. Sirolimus rescue of renal failure in children after combined liver-kidney transplantation.
    Pediatr Nephrol, 20(5): 686-9. [Abstract] [Full-text]
32. Insulin resistance, LDL particle size, and LDL susceptibility to oxidation in pediatric kidney and liver recipients.
    Kidney Int, 67(5): 2046-55. [Abstract] [Full-text]
33. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation.
    Dig Liver Dis, 37(5): 349-56. [Abstract] [Full-text]
34. Case report: hepatic artery pseudoaneurysm after liver transplantation: definitive treatment with a stent-graft after failed coil embolisation.
    Br J Radiol, 78(929): 453-6. [Abstract] [Full-text]
35. A review of aprotinin in orthotopic liver transplantation: can its harmful effects offset its beneficial effects?
    Anesth Analg, 100(5): 1248-55. [Abstract] [Full-text]
36. Recurrence rate and transplantability after liver resection in patients with hepatocellular carcinoma who initially met transplantation criteria.
    Transplant Proc, 37(2): 1254-6. [Abstract] [Full-text]
37. Microvascular tumor embolism: independent prognostic factor after liver transplantation in hepatocellular carcinoma.
    Transplant Proc, 37(2): 1251-3. [Abstract] [Full-text]
38. Transjugular intrahepatic portosystemic shunts for refractory ascites after liver transplantation.
    Transplant Proc, 37(2): 1248-50. [Abstract] [Full-text]
39. Comparison between nifedipine and carvedilol in the treatment of de novo arterial hypertension after liver transplantation: preliminary results of a controlled clinical trial.
    Transplant Proc, 37(2): 1245-7. [Abstract] [Full-text]
40. Methicillin-resistant Staphylococcus aureus infection in liver transplantation: a matched controlled study.
    Transplant Proc, 37(2): 1243-4. [Abstract] [Full-text]
41. Review of 31 cases of morphologic hepatitis in liver transplant patients not related to disease recurrence.
    Transplant Proc, 37(2): 1240-2. [Abstract] [Full-text]
42. Interferon combined with cyclosporine treatment as an effective countermeasure against hepatitis C virus recurrence in liver transplant patients with end-stage hepatitis C virus related disease.
    Transplant Proc, 37(2): 1233-4. [Abstract] [Full-text]
43. HHV-6-DNAemia related to CMV-DNAemia after liver transplantation.
    Transplant Proc, 37(2): 1230-2. [Abstract] [Full-text]
44. DNA microarray-based gene expression profiles of cytomegalovirus infection and acute rejection in liver transplants.
    Transplant Proc, 37(2): 1227-9. [Abstract] [Full-text]
45. Infectious complications limit the outcome of liver transplantation in medical urgency code 2 patients.
    Transplant Proc, 37(2): 1224-6. [Abstract] [Full-text]
46. Nephrotoxic effects of immunosuppressant therapy in pediatric liver transplant recipients.
    Transplant Proc, 37(2): 1220-3. [Abstract] [Full-text]
47. Steroid-free induction and preemptive antiviral therapy for liver transplant recipients with hepatitis C: a preliminary report from a prospective randomized study.
    Transplant Proc, 37(2): 1217-9. [Abstract] [Full-text]
48. Preliminary analysis of early outcomes of a prospective, randomized trial of complete steroid avoidance in liver transplantation.
    Transplant Proc, 37(2): 1214-6. [Abstract] [Full-text]
49. Conversion of stable liver transplant recipients from a twice-daily Prograf-based regimen to a once-daily modified release tacrolimus-based regimen.
    Transplant Proc, 37(2): 1211-3. [Abstract] [Full-text]
50. Tacrolimus for primary liver transplantation: 12 to 15 years actual follow-up with safety profile.
    Transplant Proc, 37(2): 1207-10. [Abstract] [Full-text]
51. New strategy for ABO-incompatible living donor liver transplantation with anti-CD20 antibody (rituximab) and plasma exchange.
    Transplant Proc, 37(2): 1205-6. [Abstract] [Full-text]
52. The impact of Campath 1H induction in adult liver allotransplantation.
    Transplant Proc, 37(2): 1203-4. [Abstract] [Full-text]
53. Experience of a successful pediatric liver transplant program in Mexico.
    Transplant Proc, 37(2): 1201-2. [Abstract] [Full-text]
54. Pregnancy and delivery after liver transplantation.
    Transplant Proc, 37(2): 1197-200. [Abstract] [Full-text]
55. Decrease of CD4+CD25+ T cells in peripheral blood after liver transplantation: association with immunosuppression.
    Transplant Proc, 37(2): 1194-6. [Abstract] [Full-text]
56. Livers transplanted from donors after cardiac death occurring in the ICU or the operating room have excellent outcomes.
    Transplant Proc, 37(2): 1188-93. [Abstract] [Full-text]
57. Adult liver transplantation using liver grafts from donors over 70 years of age.
    Transplant Proc, 37(2): 1186-7. [Abstract] [Full-text]
58. Does the liver ever age? Results of liver transplantation with donors above 80 years of age.
    Transplant Proc, 37(2): 1182-5. [Abstract] [Full-text]
59. Liver transplantation using livers from septuagenarian and octogenarian donors: an underused strategy to reduce mortality on the waiting list.
    Transplant Proc, 37(2): 1180-1. [Abstract] [Full-text]
60. Living donor liver transplantation for hepatocellular carcinoma: a special reference to a preoperative des-gamma-carboxy prothrombin value.
    Transplant Proc, 37(2): 1177-9. [Abstract] [Full-text]
61. Orthotopic liver transplantation for alagille syndrome.
    Transplant Proc, 37(2): 1174-6. [Abstract] [Full-text]
62. Long-term outcome of right split in situ grafts in adults.
    Transplant Proc, 37(2): 1170-3. [Abstract] [Full-text]
63. Right hemiliver transplant: results from living and cadaveric donors.
    Transplant Proc, 37(2): 1167-9. [Abstract] [Full-text]
64. Use of extended right grafts from in situ split livers in adult liver transplantation: a comparison with whole-liver transplants.
    Transplant Proc, 37(2): 1164-6. [Abstract] [Full-text]
65. Liver retransplantation: a single-center outcome and financial analysis.
    Transplant Proc, 37(2): 1161-3. [Abstract] [Full-text]
66. Risk factors predicting survival of liver transplantation.
    Transplant Proc, 37(2): 1155-60. [Abstract] [Full-text]
67. Orthotopic liver transplantation for biliary atresia.
    Transplant Proc, 37(2): 1153-4. [Abstract] [Full-text]
68. Daclizumab induction therapy associated with tacrolimus-MMF has better outcome compared with tacrolimus-MMF alone in pediatric living donor liver transplantation.
    Transplant Proc, 37(2): 1151-2. [Abstract] [Full-text]
69. Orthotopic liver transplantation for Byler's disease.
    Transplant Proc, 37(2): 1149-50. [Abstract] [Full-text]
70. Liver transplantation in children weighting less than 6 kg: the Bergamo experience.
    Transplant Proc, 37(2): 1143-5. [Abstract] [Full-text]
71. Early portal vein thrombosis after pediatric split liver transplantation with left lateral segment graft.
    Transplant Proc, 37(2): 1141-2. [Abstract] [Full-text]
72. Portal vein complications in the long-term course after pediatric living donor liver transplantation.
    Transplant Proc, 37(2): 1138-40. [Abstract] [Full-text]
73. Liver transplantation for children: Red Cross Children's Hospital experience.
    Transplant Proc, 37(2): 1134-7. [Abstract] [Full-text]
74. Efficacy of auxiliary partial orthotopic liver transplantation for cure of hemophilia in a canine hemophilia A model.
    Transplant Proc, 37(2): 1131-3. [Abstract] [Full-text]
75. Cost/efficacy clinical trial about the use of T-tube in cadaveric donor liver transplant: preliminary results.
    Transplant Proc, 37(2): 1129-30. [Abstract] [Full-text]
76. Role of choledochojejunostomy in liver transplantation.
    Transplant Proc, 37(2): 1126-8. [Abstract] [Full-text]
77. Transhepatic biliary catheterization before graft implant in living donor liver transplantation.
    Transplant Proc, 37(2): 1124-5. [Abstract] [Full-text]
78. Biliary reconstruction and complications of left lobe living donor liver transplantation.
    Transplant Proc, 37(2): 1122-3. [Abstract] [Full-text]
79. Liver transplantation in recipients with portal vein thrombosis: experience of a single transplant center.
    Transplant Proc, 37(2): 1119-21. [Abstract] [Full-text]
80. A new venous conduit utilizing the recipient portal vein branches for segment V in adult partial liver transplantation.
    Transplant Proc, 37(2): 1117-8. [Abstract] [Full-text]
81. The significance of hepatic vein outflow volume in hepatic outflow insufficiency of living right liver graft evaluated by Doppler ultrasound.
    Transplant Proc, 37(2): 1115-6. [Abstract] [Full-text]
82. Surgical procedures for decompression of excessive shear stress in small-for-size living donor liver transplantation--new hepatic vein reconstruction.
    Transplant Proc, 37(2): 1108-11. [Abstract] [Full-text]
83. Neuropsychological and neurophysiological evaluation in cirrhotic patients with minimal hepatic encephalopathy undergoing liver transplantation.
    Transplant Proc, 37(2): 1104-7. [Abstract] [Full-text]
84. Multiple organ failure caused by end-stage liver disease successfully treated with living donor liver transplantation using perioperative percutaneous cardiopulmonary support: a case report.
    Transplant Proc, 37(2): 1101-3. [Abstract] [Full-text]
85. DR antigens influence graft outcome and HCV recurrence after liver transplantation.
    Transplant Proc, 37(2): 1099-100. [Abstract] [Full-text]
86. Liver transplantation in fulminant hepatic failure: experience with 40 adult patients over a 17-year period.
    Transplant Proc, 37(2): 1085-7. [Abstract] [Full-text]
87. Decision-related factors and attitudes toward donation in living related liver transplantation: ten-year experience.
    Transplant Proc, 37(2): 1081-4. [Abstract] [Full-text]
88. Results of 132 hepatectomies for living donor liver transplantation: report of one death.
    Transplant Proc, 37(2): 1079-80. [Abstract] [Full-text]
89. Domino liver transplantation in living donors.
    Transplant Proc, 37(2): 1076-8. [Abstract] [Full-text]
90. Imaging of hepatic arterial anatomy for depicting vascular variations in living related liver transplant donor candidates with multidetector computed tomography: comparison with conventional angiography.
    Transplant Proc, 37(2): 1070-3. [Abstract] [Full-text]
91. Anatomic variation of the right hepatic artery and its reconstruction for living donor liver transplantation using right lobe graft.
    Transplant Proc, 37(2): 1067-9. [Abstract] [Full-text]
92. The main hepatic anatomic variations for the purpose of split-liver transplantation.
    Transplant Proc, 37(2): 1063-6. [Abstract] [Full-text]
93. Computerized CT-based 3D visualization technique in living related liver transplantation.
    Transplant Proc, 37(2): 1059-62. [Abstract] [Full-text]
94. Mutation scanning of the p53 tumor suppressor gene in renal and liver transplant patients in Hungary.
    Transplant Proc, 37(2): 969-72. [Abstract] [Full-text]
95. Prostate cancer prior to solid organ transplantation: the Israel Penn International Transplant Tumor Registry experience.
    Transplant Proc, 37(2): 958-9. [Abstract] [Full-text]
96. Chemotherapy for posttransplant lymphoproliferative disorder: the Israel Penn International Transplant Tumor Registry experience.
    Transplant Proc, 37(2): 956-7. [Abstract] [Full-text]
97. Excellent liver transplant survival rates under the MELD/PELD system.
    Transplant Proc, 37(2): 585-8. [Abstract] [Full-text]
98. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation.
    Hepatology, 41(5): 1130-7. [Abstract] [Full-text]
99. The downstream financial effect of hepatology.
    Hepatology, 41(5): 968-75. [Abstract] [Full-text]
100. Management of hepatitis C virus infection in the setting of liver transplantation.
     Liver Transpl, 11(5): 479-89. [Abstract] [Full-text]
101. Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression.
     Liver Transpl, 11(5): 497-503. [Abstract] [Full-text]
102. Antibodies against cytokeratin 8/18 in a patient with de novo autoimmune hepatitis after living-donor liver transplantation.
     Liver Transpl, 11(5): 504-7. [Abstract] [Full-text]
103. Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants.
     Liver Transpl, 11(5): 532-8. [Abstract] [Full-text]
104. An open, randomized, multicenter clinical trial of oral tacrolimus in liver allograft transplantation: a comparison of dual vs. triple drug therapy.
     Liver Transpl, 11(5): 515-24. [Abstract] [Full-text]
105. Improved rat liver preservation by hypothermic continuous machine perfusion using polysol, a new, enriched preservation solution.
     Liver Transpl, 11(5): 539-46. [Abstract] [Full-text]
106. Liver transplantation for severe hepatic graft-versus-host disease: an analysis of aggregate survival data.
     Liver Transpl, 11(5): 525-31. [Abstract] [Full-text]
107. Intragraft expression of recipient-type ABO blood group antigens: long-term follow-up and histological features after liver transplantation.
     Liver Transpl, 11(5): 547-54. [Abstract] [Full-text]
108. Initial hepatic microcirculation correlates with early graft function in human orthotopic liver transplantation.
     Liver Transpl, 11(5): 555-63. [Abstract] [Full-text]
109. Ablation therapy in containing extension of hepatocellular carcinoma: a simulative analysis of dropout from the waiting list for liver transplantation.
     Liver Transpl, 11(5): 508-14. [Abstract] [Full-text]
110. Liver transplantation with monosegments. Technical aspects and outcome: a meta-analysis.
     Liver Transpl, 11(5): 564-9. [Abstract] [Full-text]
111. Living donor liver transplantation with noninvasive ventilation for exertional heat stroke and severe rhabdomyolysis.
     Liver Transpl, 11(5): 570-2. [Abstract] [Full-text]
112. Nonischemic cardiomyopathy after orthotopic liver transplantation: a report of three cases and a review of the literature.
     Liver Transpl, 11(5): 573-8. [Abstract] [Full-text]
113. Preclinical experiment of auxiliary partial orthotopic liver transplantation as a curative treatment for hemophilia.
     Liver Transpl, 11(5): 579-84. [Abstract] [Full-text]
114. Natural history of hepatopulmonary syndrome: Impact of liver transplantation.
     Hepatology, 41(5): 1122-9. [Abstract] [Full-text]
115. Acute liver rejection: accuracy and predictive values of doppler US measurements--initial experience.
     Radiology, 235(2): 651-8. [Abstract] [Full-text]
116. Characterization of the humoral immune response in two paediatric patients transplanted with split livers from ABO-incompatible living-related donors: appearance of cytomegalovirus-induced ABO antibodies.
     Transfus Med, 15(2): 137-44. [Abstract] [Full-text]

© 2005-2008 Liver Transplant Research Today. All Rights Reserved.